John Seeley
Neurology · Overland Park, KSNPI 1649207135
Payments from drug & device makers
Across 761 payments — averaging $13.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$1K
- AbbVie$916
- Novartis$816
- Biogen$631
- EMD Serono, Inc.$576
- Sanofi$517
- plus $6K from 44 others
What the payments were for
- Speaking & faculty fees$1261%
- Food & beverage$10,51599%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$10,641 in reported general payments places this provider in the 75th percentile of 131 neurology providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam ErLevetiracetam | 14 | $2,283 |
| Levetiracetam | 13 | $632 |
| Lamotrigine | 16 | $327 |
Paid to pharmacies, not to this prescriber.
Other neurology in Overland Park
- Stacy YoungerOverland Park$22K
- David ClarkOverland Park$22K
- Laura ReillyOverland Park$5K
- Phaedra DowellOverland Park$3K
- Ivan OsorioKansas City$101.7M
- Sharon LynchKansas City$9.3M
- Jeffrey BurnsKansas City$6.2M
- Rajesh PahwaKansas City$5M
- Jeffrey KaplanLenexa$4.4M
- Mamatha PasnoorKansas City$3.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.